DVA: DaVita Inc. Stock

by  •  • Comments Off on DVA: DaVita Inc. Stock

SIC 809 – Miscellaneous Health And Allied Services, Not

Valuation
Market Cap ($M) 13,234.80
Enterprise Value ($M) 23,553.57
Book Value ($M) 2,219.67
Book Value / Share 27.07
Price / Book 5.96
NCAV ($M) -11,247.06
NCAV / Share -137.16
Price / NCAV -1.18

Profitability (mra)
Return on Invested Capital (ROIC) 0.06
Return on Assets (ROA) 0.05
Return on Equity (ROE) 0.29

Liquidity (mrq)
Quick Ratio 1.33
Current Ratio 1.37

Balance Sheet (mrq) ($M)
Current Assets 4,037.00
Assets 17,503.74
Liabilities 15,284.06
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
08-08 13D/A Berkshire Hathaway Inc 43.00 0.00
02-13 13G/A Vanguard Group Inc 6.92 2.51
01-31 13G/A BlackRock, Inc. 5.20 -0.66

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO
2024-02-14 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-21 189,836 537,094 35.35
2024-11-20 278,422 807,895 34.46
2024-11-19 210,571 634,094 33.21
2024-11-18 225,115 771,694 29.17

(click for more detail)

Similar Companies
AGL – agilon health, inc.


Financial data and stock pages provided by
Fintel.io